Impact of Vasculitis on Employment and Income

Vasculitis Clinical Trial

Official title:

Impact of Vasculitis on Employment and Income. An Online Survey of Participants in the VCRC Patient Contact Registry

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02476292
• Other study ID #: VCRC 5536
• Status: Completed
• Phase: N/A
• First received: June 12, 2015
• Last updated: January 26, 2016
• Start date: June 2015
• Est. completion date: January 2016

Study information

• Verified date: January 2016
• Source: University of South Florida
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to learn about the impact of vasculitis on employment and income in patients with different systemic vasculitides. All patients enrolled in the Vasculitis Clinical Research Consortium (VCRC) Patient Contact Registry, living in USA or Canada, and followed for more than 1 year since the vasculitis diagnosis will be invited via email to participate in this study, based on an online survey.

Description:

All individuals with vasculitis participating in the VCRC contact patient registry, living in the USA or Canada, and with a follow-up period of ≥1 year since the diagnosis of vasculitis will be invited by email to complete an online questionnaire. They will be asked several questions about their disease, their employment and work status before diagnosis and over the course of their disease, their work capacity and the financial impact on their lives.

The survey data will be stored by the Rare Diseases Clinical Research Network's Data Management and Coordinating Center (DMCC) at the University of South Florida. The data will be de-identified. Names or other personal health information will not be collected. If a participant is enrolled in the Vasculitis Patient-Powered Research Network (V-PPRN) University of South Florida (USF) Institutional Review Board Pro00018514, the participant can choose to provide their email address. Upon conclusion of the study period, the data will be sent to the VCRC Principal Investigator and the Protocol 5536 Co-Principal Investigators. All data collected will be sent to the database of Genotypes and Phenotypes (dbGaP) to be stored indefinitely per the Rare Disease Clinical Research Network (RDCRN) Data Sharing Policy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 426
• Est. completion date: January 2016
• Est. primary completion date: January 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Diagnosis of a systemic vasculitis: VCRC Patient Contact Registry includes patients with Behcet's disease, CNS vasculitis, Cryoglobulinemic vasculitis (Cryoglobulinemia), eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (CSS), giant cell (temporal) arteritis (GCA), granulomatosis with polyangiitis (Wegener's) (GPA), Henoch-Schönlein purpura (IgA vasculitis), microscopic polyangiitis (MPA), polyarteritis nodosa (PAN), Takayasu arteritis (TAK), and urticarial vasculitis.

• Age =18 years old

• Living in USA or Canada

• Vasculitis diagnosis made =1 year ago

• Language requirements: questionnaire will be in English only

Exclusion Criteria:

• Inability to provide informed consent and complete survey

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Arteritis
• Behcet Syndrome
• Behcet's Disease
• CNS Vasculitis
• Cryoglobulinemic Vasculitis
• Eosinophilic Granulomatosis
• Giant Cell Arteritis
• Henoch-Schoenlein Purpura
• Microscopic Polyangiitis
• Polyarteritis Nodosa
• Polyarteritis Nodosa (PAN)
• Purpura, Schoenlein-Henoch
• Systemic Vasculitis
• Takayasu Arteritis
• Takayasu's Arteritis
• Temporal Arteritis
• Urticarial Vasculitis
• Vasculitis
• Vasculitis, Central Nervous System
• Wegener Granulomatosis

Intervention

Other:
• online questionnaire
The online questionnaire includes questions about vasculitis, employment and work status before diagnosis and over the course of the disease, work capacity and the financial impact of vasculitis.

Locations

Country	Name	City	State
United States	University of South Florida Data Management and Coordinating Center	Tampa	Florida

Sponsors (4)

Lead Sponsor	Collaborator
University of South Florida	University of Pennsylvania, University of Toronto, University of Western Ontario, Canada

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentages of patients with different types of vasculitis who report negative impact of the disease on employment status, productivity, and income.	Self-reported change in employment status, productivity, and income from the time of diagnosis to the present.	one day	No